Publications by authors named "Marta Pàez-Ribes"

14Publications

Targeting senescent cells in translational medicine.

EMBO Mol Med 2019 12 19;11(12):e10234. Epub 2019 Nov 19.

Department of Oncology, CRUK Cambridge Centre Early Detection Programme, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK.

View Article and Find Full Text PDF
December 2019

Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3.

Cell Rep 2019 06;27(13):3956-3971.e6

Epigenetics & Cellular Senescence Group, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK; Centre for Genomics and Child Health, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK. Electronic address:

View Article and Find Full Text PDF
June 2019

Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents.

Cancer Res 2019 Oct 25;79(20):5328-5341. Epub 2019 Jun 25.

Tumor Angiogenesis Group, ProCURE Research Program, Catalan Institute of Oncology, OncoBell Program, IDIBELL, Barcelona, Spain.

View Article and Find Full Text PDF
October 2019

Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.

PLoS One 2016 29;11(6):e0158034. Epub 2016 Jun 29.

Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Canada.

View Article and Find Full Text PDF
July 2017

Potential Proinvasive or Metastatic Effects of Preclinical Antiangiogenic Therapy Are Prevented by Concurrent Chemotherapy.

Clin Cancer Res 2015 Dec 13;21(24):5488-98. Epub 2015 Jul 13.

Biologic Sciences Platform, Sunnybrook Research Institute, Toronto, Canada. Department of Medical Biophysics, University of Toronto, Toronto, Canada.

View Article and Find Full Text PDF
December 2015

Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanib.

Sci Transl Med 2015 Apr;7(282):282ra50

Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario M4N 3M5, Canada. Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5S 2J7, Canada.

View Article and Find Full Text PDF
April 2015